FDA issues guidance on early feasibility trials for devices

10/4/2013 | Clinica (subscription required)

New guidance from the FDA outlines the information medtech manufacturers should supply to the agency when seeking investigational device exemption approval to carry out early feasibility trials. The guidance also details the requirements involving changes made to study protocols or device designs during the feasibility trial.

View Full Article in:

Clinica (subscription required)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA